NetworkNewsBreaks

MondaySep 16, 2024 11:55 am

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, today announced that it received a notice from the Nasdaq Stock Market LLC. The notice stated that the company has regained compliance with Nasdaq’s minimum bid price requirement, as stipulated in Listing Rule 5550(a)(2), and will continue trading on Nasdaq. To view the full press release, visit https://nnw.fm/hpiiV About SuperCom Since 1988, SuperCom has been a global provider of traditional and digital identity solutions, providing advanced safety, identification, and security solutions to governments and organizations, both private and public, worldwide. Through its proprietary…

Continue Reading

MondaySep 16, 2024 10:54 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Upcoming In-Person FDA Meeting to Discuss CNM-Au8

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, will be meeting in-person with the U.S. Food and Drug Administration (“FDA”) before the end of November 2024. The company announced that the meeting, which will focus on discussions about the development of the company’s proprietary CNM-Au8 for the treatment of amyotrophic lateral sclerosis (“ALS”), will include key FDA representatives, including the organization’s director of the Office on New Drugs and director of the Office of Neuroscience, as well as the Division of Neurology 1 (“DN1”) review team and key…

Continue Reading

MondaySep 16, 2024 10:32 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports TNX-801 Aligns with WHO Preferred TPP for Mpox Vaccines

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, is reporting that the World Health Organization’s (“WHO”) preferred target product profile (“TPP”) aligns with the characteristics of its proprietary TNX-801 (horsepox, live virus) vaccine; Tonix is developing the vaccine for mpox (formerly known as monkeypox). WHO released the TPP at the Mpox Research and Innovation Scientific Conference, which was held Aug. 29–30, 2024, According to the announcement, key elements of the WHO draft TPP include single-dose, durable protection, administration without special equipment and stability at ambient temperature. “The characteristics of TNX-801…

Continue Reading

MondaySep 16, 2024 9:49 am

NetworkNewsBreaks – Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) Reports on Updated Independent Definitive Feasibility Study for Waterberg Mine

Platinum Group Metals (TSX: PTM) (NYSE American: PLG), operator of the Waterberg Project, a bulk underground platinum group metals (“PGM”) deposit located on the northern limb of the Bushveld Complex in South Africa, is reporting positive results from an Independent Definitive Feasibility Study Update (“2024 DFS”) for the Waterberg Mine. The study was completed by a team of specialists, including international engineering entity Stantec Consulting International Ltd. and South African engineering firm DRA Projects SA (Pty) Ltd. The 2024 DFS is an update to the Waterberg Project's original Independent Definitive Feasibility Study published in September 2019 (“2019 DFS”). According to…

Continue Reading

MondaySep 16, 2024 9:35 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque Psoriasis, Its Promising Novel Solution

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced plans to host a scientific webinar to discuss the plaque psoriasis landscape, current treatment methods, and existing unmet needs in treating mild to moderate plaque psoriasis. The virtual panel discussion will also explore intralesional injections of the company’s novel anti-IL-17A/F VHH single domain VHH antibodies as a promising solution. Other topics will include an introduction to single domain VHH antibodies and the company’s pipeline, with panelists also reviewing the biological drug development…

Continue Reading

FridaySep 13, 2024 3:44 pm

NetworkNewsBreaks – Upstream Discusses Current Global Blockchain Regulatory Landscape, Trends in Latest Article

Upstream, a MERJ Exchange market and trading app, published a blog article today that discussed U.S. policy and how it potentially impacts global blockchain adoption. The article highlighted that uncertainty surrounding regulatory frameworks affects innovation, deters retail and institutional adoption, and creates a state of limbo for innovators and businesses alike. It further discussed countries like Japan, Singapore, Switzerland, Canada, and South Korea that have taken proactive steps to advance blockchain technology through policies, regulations, and initiatives. In contrast, the U.S. lacks clearer blockchain securities regulations, a situation that continues to impede the potential growth of the blockchain securities industry…

Continue Reading

FridaySep 13, 2024 3:30 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D expenditures and experienced other savings,” reads a recent article. “Most importantly, however, were the program updates for initiatives it embarked on for 2024. A highlight of its projects has been its glucagon-like peptide-1 (‘GLP-1’) agonist research program. GLP-1, a class of drugs, has demonstrated an…

Continue Reading

FridaySep 13, 2024 2:24 pm

NetworkNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Stands Out as Beacon of Opportunity in the Mining Sector

Torr Metals Inc.’s (TSX.V: TMET) Kolos Copper-Gold Project in British Columbia’s Quesnel Trough, a region pulsing with mining history and supported by infrastructure that keeps costs slow and operations running year-round, is strategically positioned. “And it doesn’t stop there. Torr’s Filion Project in northern Ontario sits right off the Trans-Canada Highway, with rail and power infrastructure at its doorstep, making it a prime potential target for the next big gold discovery. Then there’s the Latham Project, anchored in BC’s legendary ‘Golden Triangle,’ an area so rich in minerals that even the highways – like Highway 37 transecting the project, currently…

Continue Reading

FridaySep 13, 2024 1:34 pm

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Looking to Unlock Significant Potential at Albert Lake, Gochager Lake Properties

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian junior mining exploration and development company focused on acquiring, exploring, and developing high-quality nickel, copper and cobalt deposits. The company is actively exploring the Albert Lake and Gochager Lake properties. “Fathom Nickel’s Albert Lake property is a promising exploration target. Formerly home to the high-grade Rottenstone Mine, this expansive landholding offers significant potential for magmatic nickel sulfide mineralization. Through the addition of the Tremblay-Olson Claims in 2022, the 100%-owned property now encompasses over 90,000 hectares. Fathom’s ongoing exploration works aim to unlock the full potential of this historically productive…

Continue Reading

FridaySep 13, 2024 1:28 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Effect 1-for-100 Reverse Stock Split

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it will implement a 1-for-100 reverse stock split of its common stock, par value $0.001 per share, automatically combining and converting 100 current shares of its common stock into one issued and outstanding share of common stock. The reverse stock split, approved by the company’s stockholders and the board of directors, will take effect on September 17, 2024, at 12:01 a.m. ET. Following the split, the new CUSIP number will be 62526P505, with Mullen’s common stock trading on a split-adjusted basis under the existing ticker symbol MULN.…

Continue Reading